What is the debt of BioLine RX this year?
BioLine RX has a debt level of 8.44 USD this year.
BioLine RX Debt 2024
BioLine RX Debt
8.44 USD
Ticker
BLRX.TA
ISIN
IL0011015182
In 2024, BioLine RX's total debt was 8.44 USD, a -3.03% change from the 8.7 USD total debt recorded in the previous year.
BioLine RX Aktienanalyse
What does BioLine RX do?
BioLine RX Ltd is a global biopharmaceutical company specializing in the development of novel therapies for cancer and other serious diseases. The company is headquartered in Israel and has offices in the United States and Europe. BioLine RX ist eines der beliebtesten Unternehmen auf Eulerpool.com.Debt Details
Understanding BioLine RX's Debt Structure
BioLine RX's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.
Year-to-Year Comparison
Analyzing BioLine RX's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.
Impact on Investments
Investors pay close attention to BioLine RX’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.
Interpreting Debt Fluctuations
Shifts in BioLine RX’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.
Frequently Asked Questions about BioLine RX stock
What was the debt of BioLine RX compared to the previous year?
The debt of BioLine RX has increased by -3.03% compared to the previous year dropped.
What are the consequences of high debt for investors in BioLine RX?
High debt can pose a risk for investors of BioLine RX, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.
What are the consequences of low debt for investors of BioLine RX?
Low debt means that BioLine RX has a strong financial position and is able to fulfill its obligations without overburdening its finances.
How does an increase in debt from BioLine RX affect the company?
An increase in debt of BioLine RX can adversely affect the financial condition of the company and result in a higher burden on its finances.
How does a reduction of debt of BioLine RX affect the company?
A reduction in debt of BioLine RX can strengthen the company's financial position and improve its ability to meet its financial obligations.
What are some factors that influence the debt of BioLine RX?
Some factors that can influence the debt of BioLine RX include investments, acquisitions, operating costs, and revenue development.
Why are the debts of BioLine RX so important for investors?
The debts of BioLine RX are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.
What strategic measures can BioLine RX take to change the debt?
To change the debt, BioLine RX can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.
How much dividend does BioLine RX pay?
Over the past 12 months, BioLine RX paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, BioLine RX is expected to pay a dividend of 0 USD.
What is the dividend yield of BioLine RX?
The current dividend yield of BioLine RX is .
When does BioLine RX pay dividends?
BioLine RX pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of BioLine RX?
BioLine RX paid dividends every year for the past 0 years.
What is the dividend of BioLine RX?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is BioLine RX located?
BioLine RX is assigned to the 'Health' sector.
Wann musste ich die Aktien von BioLine RX kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of BioLine RX from 10/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/1/2024.
When did BioLine RX pay the last dividend?
The last dividend was paid out on 10/1/2024.
What was the dividend of BioLine RX in the year 2023?
In the year 2023, BioLine RX distributed 0 USD as dividends.
In which currency does BioLine RX pay out the dividend?
The dividends of BioLine RX are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von BioLine RX
Our stock analysis for BioLine RX Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of BioLine RX Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
